Researchers at Stony Brook University, Stony Brook, NY, have developed a device that can be used to optimise cardiovascular device design to eliminate the risk of clot formation.
The device thrombogenicity emulator (DTE) measures the potential that a cardiovascular device will cause a blood clot.
During the Phase I of the project, the researchers developed and tested the device in laboratory models. In the Phase II study, the researchers are planning to use DTE to identify the areas in cardiovascular devices where clots can form.
Lead researcher Danny Bluestein said that within the DTE, it is possible to tweak the geometry of the device's design to optimise it and minimise or eliminate these hot spots.
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology
